Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Local Stocks
Stocks of Local Interest
PG Energy Index
Local Stocks
Energy Stocks
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
Arrowhead Pharma
(NQ:
ARWR
)
83.44
USD
+1.29 (+1.57%)
Official Closing Price
Updated: 5:14 PM EST, Jan 20, 2021
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All news about Arrowhead Pharma
< Previous
1
2
3
4
5
6
7
8
9
...
27
28
Next >
Implied TUSA Analyst Target Price: $34
May 01, 2020
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and...
Tags
ETFs
From
ETF Channel
Is Arrowhead Pharmaceuticals Close to a Cure for HBV?
April 30, 2020
The collaboration between a pharmaceutical giant and a mid-cap biotech company may have accomplished the impossible.
Tags
Market News
JNJ
ARWR
From
Motley Fool
Arrowhead Pharmaceuticals to Webcast Fiscal 2020 Second Quarter Results
April 22, 2020
Arrowhead Pharmaceuticals will webcast fiscal 2020 second quarter earnings on May 7, 2020
From
Business Wire News Releases
ARWR Crosses Above Key Moving Average Level
April 20, 2020
In trading on Monday, shares of Arrowhead Pharmaceuticals Inc (ARWR) crossed above their 200 day moving average of $39.49, changing hands as high as $40.01 per share. Arrowhead Pharmaceuticals Inc...
Tags
Stocks
From
Market News Video
Benzinga's Top Upgrades, Downgrades For April 15, 2020
April 15, 2020
Upgrades ForAir Products & Chemicals Inc(NYSE: APD), Bernstein upgraded the stock from Market Perform to ...
Tags
GIS
IDXG
V
From
Benzinga
2 Top Small-Cap Stocks to Buy Right Now
April 15, 2020
These development-stage drug companies are well positioned for success, even amid the current market uncertainty.
Tags
DRNA
NVO
Market News
From
Motley Fool
Arrowhead Pharmaceuticals Files for Regulatory Clearance to Begin Phase 1/2a Study of ARO-ENaC for Treatment of Cystic Fibrosis
April 10, 2020
Arrowhead files to begin Phase 1/2a study of ARO-ENaC, RNAi therapeutic for Cystic Fibrosis
From
Business Wire News Releases
Surprising Analyst 12-Month Target For RWK
March 31, 2020
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and...
Tags
ETFs
From
ETF Channel
First Week of May 15th Options Trading For Arrowhead Pharmaceuticals (ARWR)
March 30, 2020
Investors in Arrowhead Pharmaceuticals Inc (ARWR) saw new options begin trading this week, for the May 15th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ARWR...
Tags
Stocks
From
Market News Video
Bragar Eagel & Squire is Investigating Certain Officers and Directors of comScore, Mammoth Energy, AMC Entertainment, and Arrowhead Pharmaceuticals and Encourages Investors to Contact the Firm
March 18, 2020
From
GlobeNewswire News Releases
Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Marketplace Rule 5635(c)(4)
March 17, 2020
Arrowhead announces March 2020 inducement grants
From
Business Wire News Releases
Arrowhead Pharmaceuticals Announces Precautionary Measures to Mitigate Effects of Novel Coronavirus (COVID-19) Spread
March 17, 2020
Arrowhead provides update related to COVID-19 efforts
From
Business Wire News Releases
58.9% Return Seen to Date on SmarTrend Arrowhead Pharma Call (ARWR)
March 13, 2020
SmarTrend identified a Downtrend for Arrowhead Pharma (NASDAQ:ARWR) on January 10th, 2020 at $58.73. In approximately 2 months, Arrowhead Pharma has returned 58.87% as of today's recent price of...
From
Comtex SmarTrend® News Briefs
Bragar Eagel & Squire is Investigating Certain Officers and Directors of comScore, Zuora, AMC Entertainment, and Arrowhead Pharmaceuticals and Encourages Investors to Contact the Firm
March 10, 2020
From
GlobeNewswire News Releases
Why Arrowhead Pharmaceuticals Shares Dropped 15% in February
March 09, 2020
After a stellar 2019, the biotech stock has lost 47% so far in 2020.
Tags
Market News
ARWR
JNJ
From
Motley Fool
52 Healthcare Stocks Moving In Monday's Pre-Market Session
March 09, 2020
Gainers Spherix, Inc.(NASDAQ: SPEX) shares surged 66.5% to $2.73 during Monday's pre-market session. Cocrystal Pharma, ...
Tags
ENLV
CGC
KMPH
From
Benzinga
Arrowhead Pharmaceuticals Initiates Phase 1/2 Study of ARO-HSD in Normal Healthy Volunteers and Patients with NASH or Suspected NASH
March 03, 2020
Arrowhead dosed the first patients in AROHSD1001, a Phase 1/2 clinical study of ARO-HSD for alcohol related and nonalcohol related liver diseases
From
Business Wire News Releases
Arrowhead Pharmaceuticals to Participate in Upcoming March 2020 Conferences
March 02, 2020
Arrowhead Pharmaceuticals will participate in multiple conference presentations in March 2020
From
Business Wire News Releases
39.8% Return Seen to Date on SmarTrend Arrowhead Pharma Call (ARWR)
March 02, 2020
SmarTrend identified a Downtrend for Arrowhead Pharma (NASDAQ:ARWR) on January 10th, 2020 at $58.73. In approximately 2 months, Arrowhead Pharma has returned 39.79% as of today's recent price of...
From
Comtex SmarTrend® News Briefs
We Did The Math IJH Can Go To $222
February 28, 2020
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and...
Tags
ETFs
From
ETF Channel
30 Stocks Moving in Tuesday's Pre-Market Session
February 18, 2020
Gainers Senmiao Technology Limited (NASDAQ: AIHS) shares rose 56.8% to $0.9250 in pre-market trading. Senmiao Technology reported ...
Tags
SPCE
AGRX
ESPR
From
Benzinga
Bragar Eagel & Squire is Investigating Certain Officers and Directors of Zuora, Arrowhead Pharmaceuticals, ResMed, and Covetrus and Encourages Investors to Contact the Firm
February 13, 2020
From
GlobeNewswire News Releases
Oversold Conditions For Arrowhead Pharmaceuticals (ARWR)
February 11, 2020
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a...
Tags
Stocks
From
Market News Video
Arrowhead Pharma Has Returned 27.7% Since SmarTrend Recommendation (ARWR)
February 11, 2020
SmarTrend identified a Downtrend for Arrowhead Pharma (NASDAQ:ARWR) on January 10th, 2020 at $58.73. In approximately 1 month, Arrowhead Pharma has returned 27.71% as of today's recent price of...
From
Comtex SmarTrend® News Briefs
Here's Why Arrowhead Pharmaceuticals Fell 33.9% in January
February 06, 2020
Investors began to question the excessive market valuation for the early-stage biopharma, but the company still has plenty of potential.
Tags
ARWR
Market News
From
Motley Fool
The Daily Biotech Pulse: Tonix Slumps On Failed Study, Applied Genetic Announces Offering, Beam Therapeutics, PPD Price IPOs
February 06, 2020
The following is a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that ...
Tags
PROF
Trading Ideas
JNCE
From
Benzinga
Arrowhead Pharmaceuticals Q1 Results Didn't Matter -- but Its Pipeline Update Did
February 06, 2020
The clinical-stage biotech posted a revenue decline and a widening net loss in Q1. But no one cared.
Tags
ARWR
Market News
From
Motley Fool
Arrowhead Pharmaceuticals Inc (ARWR) Q1 2020 Earnings Call Transcript
February 05, 2020
ARWR earnings call for the period ending December 31, 2019.
Tags
ARWR
Market News
From
Motley Fool
Arrowhead Reports Interim Clinical Data on Cardiometabolic Candidates ARO-APOC3 and ARO-ANG3
February 05, 2020
Arrowhead reports promising interim clinical results of cardiometabolic candidates ARO-APOC3 and ARO-ANG3
From
Business Wire News Releases
Arrowhead Pharmaceuticals Reports Fiscal 2020 First Quarter Results
February 05, 2020
Arrowhead Pharmaceuticals Reports Fiscal 2020 First Quarter Results
From
Business Wire News Releases
< Previous
1
2
3
4
5
6
7
8
9
...
27
28
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.